Skip to main content
Swing Capital

Chemcon Speciality Chemicals Ltd

NSE: CHEMCON BSE: 543233Pharma

Incorporated in 1988, Chemcon Speciality Chemicals Ltd manufactures Pharmaceutical intermediates and Oilfield Chemicals[1]

₹160
52W: ₹125 — ₹295
PE 27.7 · Book ₹140 · +14% vs book
Market Cap₹586 Cr
Stock P/E27.7Price to Earnings
ROCE7.01%Return on Capital
ROE5%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Stock is trading at 1.16 times its book value

Weaknesses

  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −The company has delivered a poor sales growth of -4.57% over past five years.
  • −Company has a low return on equity of 7.05% over last 3 years.
  • −Earnings include an other income of Rs.14.5 Cr.
  • −Dividend payout has been low at 8.86% of profits over last 3 years

Shareholding Pattern

Promoters74.47%
FIIs0.38%
DIIs0%
Public25.15%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters74.47%74.47%74.47%74.47%74.47%74.47%74.47%74.47%
FIIs0.25%0.25%0.25%0.32%▲0.10.3%▼0.00.27%▼0.00.32%▲0.00.38%▲0.1
DIIs0.27%0.27%0.27%0.27%0%▼0.30%0%0%
Public25.01%25.01%25.01%24.94%▼0.125.24%▲0.325.27%▲0.025.21%▼0.125.15%▼0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales75.1952.9859.5945.5252.654.3954.8953.5253.7157.33
Expenses66.8646.6455.2138.444.0943.149.145.7546.8650.67
Operating Profit8.336.344.387.128.5111.295.797.776.856.66
OPM %11.08%11.97%7.35%15.64%16.18%20.76%10.55%14.52%12.75%11.62%
Net Profit5.944.442.95.376.338.813.956.395.755.09
EPS ₹1.621.210.791.471.732.411.081.741.571.39

AI Insights

Revenue Trend

TTM revenue at ₹219Cr, up 5.8% YoY. OPM at 12%.

Debt Position

Borrowings at ₹0Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.

Capex Cycle

CWIP at ₹47Cr (33% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 0% (-0.27pp change). FIIs: 0.38% (+0.37pp change). Promoters hold 74.47%.

Margin & Efficiency

ROCE declining from 17% (Mar 2014) to 7% (Mar 2025). Working capital days: 211.

Valuation

PE 27.7x with 7.01% ROCE. Price is 14% above book value of ₹140. Dividend yield: 0%.

Recent Announcements